About this trial
Our aim is to identify patients who may experience hypotension during anesthesia induction. Intraoperative hemodynamic stability plays an important role in tissue oxygenation. Although the duration of hypotension can be kept short with the necessary interventions, it is important that hypotension is predictable in order to prevent intraoperative complications and postoperative organ damage.
40 patients scheduled for open heart surgery will be monitored from one minute before anesthesia is administered until ten minutes after. Patients will be divided into two groups based on the presence or absence of hypotension during the monitoring period. All patients will be monitored according to a standardized procedure. Demographic data, non-invasive and invasive hemodynamic parameters, primarily Eadyn, and cerebral and renal tissue saturation data will be collected. Moreover, vasopressor administration in response to hypotension will be recorded.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Presence of arrhythmia (atrial fibrillation or frequent premature beats)
Severe valvular heart disease (aortic or mitral stenosis/insufficiency)
Severe heart failure (EF < 40%)
Congenital heart disease
Trial population
Patients diagnosed with coronary artery disease who were scheduled to undergo elective open-heart surgery were included in the study.
Trial design
Cohort
Prospective
Treatments tested in this trial
mostcare hemodynamic monitor
DeviceInvasive hemodynamic variables including dynamic arterial elastance (Eadyn), stroke volume variation (SVV), pulse pressure variation (PPV), cardiac index (CI), oxygen delivery (DO₂), and cardiac power output (CPO) were obtained using the MostCare monitor.
Masimo NIRS
DeviceCerebral and renal tissue oxygen saturation(rso2) values were measured using the Masimo device.
Hemodynamic Measurements on Standart Monitoring
DeviceHeart rate and peripheral oxygen saturation were measured using standard noninvasive monitoring.
Treatment groups
Trial outcomes
Primary outcomes
Eadyn
Dynamic Arterial Elastance
rso2
Cerebral and Kidney Regional Saturation
Intraoperative hypotension
Explanatory outcome
Sponsors and contacts
Click on the lead sponsor to view all of their trials.